CAI stock

Caris Life Sciences, Inc. Common Stock (CAI) financials · rev $812.0M

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Caris Life Sciences, Inc. Common Stock (CAI) rev $812.0M.

Cached annual income statement
LineFY2025FY2024
Revenue$812.0M$412.3M
Operating Income$45.1M-$257.1M
Net Income-$68.1M-$281.9M
Cached annual balance sheet
LineFY2025
Total Assets$1.13B
Current Assets$997.8M
Cash & Equivalents$796.3M
PP&E$63.2M
Total Liabilities$548.4M
Current Liabilities$127.1M
Short-term Debt$169.0K
Long-term Debt$378.8M
Total Debt$379.0M
Shareholders' Equity$577.3M
Retained Earnings-$2.55B

† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).

Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow$83.2M-$245.2M
CapEx$16.3M$8.44M
Investing Cash Flow-$16.3M$52.9M
Financing Cash Flow$665.0M$200.3M
Net Change in Cash$732.0M$8.02M
Free Cash Flow$66.9M-$253.6M
These statements as JSON? API free 100/day

FAQ

What is CAI P/E and revenue?

Caris Life Sciences, Inc. Common Stock (CAI) rev $812.0M.

What is CAI revenue?

Caris Life Sciences, Inc. Common Stock last cached revenue is $812.0M (FY2025).

Is CAI profitable?

Caris Life Sciences, Inc. Common Stock last cached net income is -$68.1M (FY2025).

What are CAI total assets?

Caris Life Sciences, Inc. Common Stock last cached total assets are $1.13B (FY2025).

What is CAI free cash flow?

Caris Life Sciences, Inc. Common Stock last cached free cash flow is $66.9M (FY2025).

Not investment advice. Cached statements, not a live tape.